artemisia
Botanicalexperimental
Artemisia vulgaris, commonly known as mugwort, common mugwort, or wormwood, is a species of flowering plant in the daisy family Asteraceae. It is one of several species in the genus Artemisia commonly known as mugwort, although Artemisia vulgaris is the species most often called mugwort. Mugworts have been used medicinally and as culinary herbs. — Wikipedia
Clinical trial activity
23 trials · 53 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
14
Phase 3
4
Phase 4
0
Earliest trial started Mar 1, 2006 (NCT01057576)
Timeline
Indications
Studied for
- Allergy and Immunology · Phase 2
- Blind Loop Syndrome · Phase 1/Phase 2
- COVID-19 · Phase 2
- Diabetes Mellitus · Phase 2
- Dyslipidemias · Phase 1/Phase 2
- Esophageal Diseases · Phase 3
- Gastritis · Phase 3
- Glucose Intolerance · Phase 2
- Hypertension · Phase 2
- Malaria · Phase 2
- Malaria, Falciparum · Phase 2
- Metabolic Syndrome · Phase 1/Phase 2
- Nails, Malformed · Phase 3
- Obesity · Phase 2
- Ovarian Neoplasms · Phase 1
- Rhinitis, Allergic, Seasonal · Phase 3
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaArtemisia vulgaris ↗
- NCATS32MP823R8S ↗
- WikipediaArtemisia annua ↗
Also known as
- artemisia abrotanum extract
- artemisia dracunculus
- artemisia dracunculus l.
- artemisia dracunculus l. extrct
- artemisia vulgaris
- dried leaf artemisia
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06721884 | Phase 1/Phase 2 (Phase 2) | Jan 31, 2025 | National College of Natural Medicine |
| NCT06703788 | Phase 1/Phase 2 (Phase 2) | Nov 20, 2024 | Chang Gung University, Government of Taiwan |
| NCT06860763 | N/A | Oct 15, 2024 | Mahidol University, Peking University |
| NCT06628804 | N/A | Aug 1, 2024 | Pusan National University |
| NCT05801198 | Phase 2 | Mar 1, 2024 | King Faisal Hospital Rwanda |
| NCT05440773 | N/A | Apr 30, 2023 | Free University of Brussels, Université catholique de Louvain, University of Buea, University of Liege |
| NCT05360004 | Phase 2 | May 31, 2022 | Hong Kong Baptist University |
| NCT05269511 | N/A | Mar 10, 2022 | Hong Kong Baptist University |
| NCT04805333 | Phase 1 | Mar 26, 2021 | ArtemiLife, University of Kentucky |
| NCT04530617 | Phase 2 | Oct 5, 2020 | Hospital General Dr. Manuel Gea Gonzalez, Instituto Nacional de Cardiologia Ignacio Chavez, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, National Autonomous University of Mexico |
| NCT04255589 | Phase 3 | Jan 6, 2020 | Chong Kun Dang Pharmaceutical |
| NCT03577938 | N/A | Sep 1, 2018 | Capital Medical University, China Medical University, Fudan University, Fuzhou Infectious Hospital, Government of China, Guangxi Medical University, Hangzhou Xixi hospital, Henan Medical University, Hepatobiliary Disease Hospital of Jilin Province, Jilin, China, Huazhong University of Science and Technology, Hubei University of Chinese Medicine, Hunan University of Traditional Chinese Medicine, Jilin University, People's Liberation Army of China, Shanghai University of Traditional Chinese Medicine, Shenzhen Third People's Hospital, Shenzhen University, Sun Yat-Sen University, Xiamen University |
| NCT03437785 | Phase 2 | Jan 16, 2018 | Chong Kun Dang Pharmaceutical |
| NCT03366922 | N/A | Dec 10, 2017 | ANAMED, Mbarara University of Science and Technology |
| NCT03199755 | Phase 2 | Aug 1, 2017 | HEAL Africa Hospital, Goma, Democratic Republic of Congo, Plesion International, Rwanguba Reference Hospital, Rwanguba, Democratic Republic of Congo, Worcester Polytechnic Institute |
| NCT03649139 | Phase 3 | Jul 1, 2017 | Capital Medical University, Zhejiang Wolwo Bio-pharmaceutical Co. LTD. |
| NCT03998969 | Phase 3 | Jun 1, 2016 | Dong-A Pharmaceutical, Seoul National University |
| NCT02582762 | Phase 3 | Sep 1, 2015 | Mahidol University |
| NCT02330341 | Phase 2 | Dec 1, 2014 | University of Guadalajara |
| NCT01984541 | Phase 2 | Mar 1, 2014 | Leti Pharma GmbH |
Showing 20 of 23 trials
Page 1 / 2
Organizations
Research & Development (53)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Capital Medical University | Academic/Hospital | 2 | 1 | 2 | 2017 |
| Chong Kun Dang Pharmaceutical | For profit | 2 | 2 | 2 | 2018 |
| Hong Kong Baptist University | Academic/Hospital | 2 | 2 | 2 | 2022 |
| Mahidol University | Academic/Hospital | 2 | 1 | 2 | 2015 |
| University of Vermont | Academic/Hospital | 2 | 2 | 2 | 2006 |
| ANAMED | Academic/Hospital | 1 | 0 | 1 | 2017 |
| ArtemiLife | For profit | 1 | 0 | 1 | 2021 |
| Chang Gung University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| China Academy of Chinese Medical Sciences | Academic/Hospital | 1 | 1 | 1 | 2012 |
| China Medical University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Dong-A Pharmaceutical | For profit | 1 | 0 | 1 | 2016 |
| Free University of Brussels | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Fuzhou Infectious Hospital | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Government of China | Government | 1 | 0 | 1 | 2018 |
| Government of Taiwan | Government | 1 | 0 | 1 | 2024 |
| Guangxi Medical University | Academic/Hospital | 1 | 0 | 1 | 2018 |
| Hangzhou Xixi hospital | Academic/Hospital | 1 | 0 | 1 | 2018 |
| HEAL Africa Hospital, Goma, Democratic Republic of Congo | Academic/Hospital | 1 | 0 | 1 | 2017 |
| Henan Medical University | Academic/Hospital | 1 | 0 | 1 | 2018 |
53 organizations
Page 1 / 3